相关实验视频

Updated: Jun 21, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

妇女在非小细胞肺癌临床试验中的代表性不足:系统性审查

Savan K Shah1, Vaishnavi Krishnan1, Arsalan A Khan1

  • 1Department of Cardiovascular and Thoracic Surgery, Rush University Medical Center, Chicago, IL, USA.

Annals of surgical oncology
|July 10, 2024
PubMed
概括

妇女在非小细胞肺癌 (NSCLC) 临床试验中的代表性仍然不足,尽管近年来出现了一些改善. 这一系统性审查强调了持续需要公平参与肺癌研究的需要.

关键词:
股权资本 股权资本雌性 雌性 雌性肺癌是一种肺癌.在NSCLCLC中,我们可以看到NSCLCLC.代表性 代表性 代表性女人 女人 女人 女人 女人

更多相关视频

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

956
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.9K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K